← Back to search results

AwardedFind a Tender · award

Managed Service Contract for the Bacterial Screening of Platelets

Buyer: NHS Blood and Transplant →

BuyerNHS Blood and Transplant
StatusAwarded
DeadlineNot published
ValueValue not published
Published6 Dec 2023

What is being bought

A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.

Delivery location

UK

Categories

Microbiological cultures 33698100Blood analysers 38434520Automation system 48921000Technical testing, analysis and consultancy services 71600000Technical testing services 71632000Laboratory services 71900000Blood analysis services 85111810Services provided by blood banks 85146000Blood analysis services 85111810

Lot details

Lot 1

A direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which includes all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.<br/><br/>A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year. The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components.

Statuscancelled

Award criteria
Technical — 10
price — 90

What is included

ItemCategoryQuantity
1Automation system, Laboratory services, Blood analysers, Microbiological cultures, Technical testing services, Technical testing, analysis and consultancy services, Blood analysis services, Services provided by blood banksNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Microbiological cultures (33698100); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 334,8542 median · 122.5 average (2,277 of 4,854 with a bid count)5.8 average (2,723 of 4,854 with named award suppliers)Not published
Same buyer711 median · 4.7 average (29 of 71 with a bid count)1.3 average (37 of 71 with named award suppliers)Not published
Delivery region: UK1,4327 median · 323.6 average (651 of 1,432 with a bid count)10 average (787 of 1,432 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byGPA
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Awards

Contracts

035879-2023-1

Statusactive
Value£47,085,000

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-03590d
Latest release ID035879-2023
Latest release timestampWed Dec 06 2023 09:12:58 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statuscomplete
Procurement methodopen
Procurement method detailsOpen procedure
Main procurement categoryservices
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release1
Contracts in latest release1
Parties in latest release3

Notice history

DateEventReference
6 Dec 2023award, contract035879-2023
24 Feb 2023tender005555-2023
4 Aug 2022planning021457-2022

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "035879-2023",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 1,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "1"
      },
      {
        "id": "3",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "1"
      },
      {
        "id": "4",
        "value": 1,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1"
      },
      {
        "id": "5",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2023-12-06T09:12:58Z",
  "ocid": "ocds-h6vhtk-03590d",
  "buyer": {
    "id": "GB-FTS-18293",
    "name": "NHS Blood and Transplant"
  },
  "awards": [
    {
      "id": "035879-2023-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-100092",
          "name": "Biomerieux UK Limited"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "C116642",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "hasOptions": false,
        "description": "A direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which includes all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.<br/><br/>A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.  The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Technical",
              "type": "quality",
              "description": "10"
            },
            {
              "type": "price",
              "description": "90"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "48921000",
            "scheme": "CPV",
            "description": "Automation system"
          },
          {
            "id": "71900000",
            "scheme": "CPV",
            "description": "Laboratory services"
          },
          {
            "id": "38434520",
            "scheme": "CPV",
            "description": "Blood analysers"
          },
          {
            "id": "33698100",
            "scheme": "CPV",
            "description": "Microbiological cultures"
          },
          {
            "id": "71632000",
            "scheme": "CPV",
            "description": "Technical testing services"
          },
          {
            "id": "71600000",
            "scheme": "CPV",
            "description": "Technical testing, analysis and consultancy services"
          },
          {
            "id": "85111810",
            "scheme": "CPV",
            "description": "Blood analysis services"
          },
          {
            "id": "85146000",
            "scheme": "CPV",
            "description": "Services provided by blood banks"
          }
        ]
      }
    ],
    "title": "Managed Service Contract for the Bacterial Screening of Platelets",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.",
    "classification": {
      "id": "85111810",
      "scheme": "CPV",
      "description": "Blood analysis services"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-18293",
      "name": "NHS Blood and Transplant",
      "roles": [
        "buyer",
        "reviewContactPoint"
      ],
      "address": {
        "region": "UKK11",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "500 North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "buyerProfile": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood and Transplant"
      },
      "contactPoint": {
        "name": "Jo Murphy",
        "email": "jo.murphy@nhsbt.nhs.uk",
        "telephone": "+44 1179212718"
      }
    },
    {
      "id": "GB-FTS-100092",
      "name": "Biomerieux UK Limited",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Basingstoke",
        "postalCode": "RG24 8NA",
        "countryName": "United Kingdom",
        "streetAddress": "Chineham Gate, Crockford Lane"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Biomerieux UK Limited"
      }
    },
    {
      "id": "GB-FTS-1661",
      "name": "The High Court",
      "roles": [
        "reviewBody",
        "mediationBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "identifier": {
        "legalName": "The High Court"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "035879-2023-1",
      "value": {
        "amount": 47085000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "035879-2023-1",
      "dateSigned": "2023-12-04T00:00:00Z"
    }
  ],
  "initiationType": "tender"
}
Complete JSON history (3 releases)
6 Dec 2023 · 035879-2023 · award, contract
{
  "id": "035879-2023",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 1,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "1"
      },
      {
        "id": "3",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "1"
      },
      {
        "id": "4",
        "value": 1,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1"
      },
      {
        "id": "5",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2023-12-06T09:12:58Z",
  "ocid": "ocds-h6vhtk-03590d",
  "buyer": {
    "id": "GB-FTS-18293",
    "name": "NHS Blood and Transplant"
  },
  "awards": [
    {
      "id": "035879-2023-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-100092",
          "name": "Biomerieux UK Limited"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "C116642",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "hasOptions": false,
        "description": "A direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which includes all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.<br/><br/>A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.  The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Technical",
              "type": "quality",
              "description": "10"
            },
            {
              "type": "price",
              "description": "90"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "48921000",
            "scheme": "CPV",
            "description": "Automation system"
          },
          {
            "id": "71900000",
            "scheme": "CPV",
            "description": "Laboratory services"
          },
          {
            "id": "38434520",
            "scheme": "CPV",
            "description": "Blood analysers"
          },
          {
            "id": "33698100",
            "scheme": "CPV",
            "description": "Microbiological cultures"
          },
          {
            "id": "71632000",
            "scheme": "CPV",
            "description": "Technical testing services"
          },
          {
            "id": "71600000",
            "scheme": "CPV",
            "description": "Technical testing, analysis and consultancy services"
          },
          {
            "id": "85111810",
            "scheme": "CPV",
            "description": "Blood analysis services"
          },
          {
            "id": "85146000",
            "scheme": "CPV",
            "description": "Services provided by blood banks"
          }
        ]
      }
    ],
    "title": "Managed Service Contract for the Bacterial Screening of Platelets",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "A fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.",
    "classification": {
      "id": "85111810",
      "scheme": "CPV",
      "description": "Blood analysis services"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-18293",
      "name": "NHS Blood and Transplant",
      "roles": [
        "buyer",
        "reviewContactPoint"
      ],
      "address": {
        "region": "UKK11",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "500 North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "buyerProfile": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood and Transplant"
      },
      "contactPoint": {
        "name": "Jo Murphy",
        "email": "jo.murphy@nhsbt.nhs.uk",
        "telephone": "+44 1179212718"
      }
    },
    {
      "id": "GB-FTS-100092",
      "name": "Biomerieux UK Limited",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Basingstoke",
        "postalCode": "RG24 8NA",
        "countryName": "United Kingdom",
        "streetAddress": "Chineham Gate, Crockford Lane"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Biomerieux UK Limited"
      }
    },
    {
      "id": "GB-FTS-1661",
      "name": "The High Court",
      "roles": [
        "reviewBody",
        "mediationBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "identifier": {
        "legalName": "The High Court"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "035879-2023-1",
      "value": {
        "amount": 47085000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "035879-2023-1",
      "dateSigned": "2023-12-04T00:00:00Z"
    }
  ],
  "initiationType": "tender"
}
24 Feb 2023 · 005555-2023 · tender
{
  "id": "005555-2023",
  "tag": [
    "tender"
  ],
  "date": "2023-02-24T13:48:30Z",
  "ocid": "ocds-h6vhtk-03590d",
  "buyer": {
    "id": "GB-FTS-18293",
    "name": "NHS Blood and Transplant"
  },
  "tender": {
    "id": "ocds-h6vhtk-03590d",
    "lots": [
      {
        "id": "1",
        "value": {
          "amount": 29270000,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "3 x 1 year extension options."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.<br/><br/>NHSBT are looking for a fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.  The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components.",
        "contractPeriod": {
          "durationInDays": 2520
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "48921000",
            "scheme": "CPV",
            "description": "Automation system"
          },
          {
            "id": "71900000",
            "scheme": "CPV",
            "description": "Laboratory services"
          },
          {
            "id": "71632000",
            "scheme": "CPV",
            "description": "Technical testing services"
          },
          {
            "id": "85111810",
            "scheme": "CPV",
            "description": "Blood analysis services"
          },
          {
            "id": "71600000",
            "scheme": "CPV",
            "description": "Technical testing, analysis and consultancy services"
          },
          {
            "id": "85146000",
            "scheme": "CPV",
            "description": "Services provided by blood banks"
          },
          {
            "id": "38434520",
            "scheme": "CPV",
            "description": "Blood analysers"
          },
          {
            "id": "33698100",
            "scheme": "CPV",
            "description": "Microbiological cultures"
          }
        ]
      }
    ],
    "title": "Managed Service for the Bacterial Screening of Platelets",
    "status": "active",
    "coveredBy": [
      "GPA"
    ],
    "documents": [
      {
        "id": "economic",
        "documentType": "economicSelectionCriteria"
      },
      {
        "id": "technical",
        "documentType": "technicalSelectionCriteria"
      }
    ],
    "bidOpening": {
      "date": "2023-03-28T17:00:00+01:00"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "awardPeriod": {
      "startDate": "2023-03-28T17:00:00+01:00"
    },
    "description": "NHSBT are looking for a fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year.",
    "tenderPeriod": {
      "endDate": "2023-03-28T17:00:00+01:00"
    },
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
    },
    "hasRecurrence": true,
    "classification": {
      "id": "85111810",
      "scheme": "CPV",
      "description": "Blood analysis services"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "bidValidityPeriod": {
        "endDate": "2023-09-28T23:59:59+01:00"
      }
    },
    "submissionMethod": [
      "electronicSubmission",
      "written"
    ],
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-18293",
      "name": "NHS Blood and Transplant",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK11",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "500 North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "buyerProfile": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood and Transplant"
      },
      "contactPoint": {
        "url": "https://health-family.force.com/s/Welcome",
        "name": "Jo Murphy",
        "email": "jo.murphy@nhsbt.nhs.uk",
        "telephone": "+44 1179212718"
      }
    },
    {
      "id": "GB-FTS-1661",
      "name": "The High Court",
      "roles": [
        "reviewBody",
        "mediationBody",
        "reviewContactPoint"
      ],
      "address": {
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "countryName": "United Kingdom",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "identifier": {
        "legalName": "The High Court"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}
4 Aug 2022 · 021457-2022 · planning
{
  "id": "021457-2022",
  "tag": [
    "planning"
  ],
  "date": "2022-08-04T16:03:11+01:00",
  "ocid": "ocds-h6vhtk-03590d",
  "buyer": {
    "id": "GB-FTS-17015",
    "name": "NHS Blood and Transplant"
  },
  "tender": {
    "id": "ocds-h6vhtk-03590d",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below.  All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked.  GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.  <br/><br/>NHSBT are looking for a fully integrated, high throughput, automated bacterial screening system which can detect bacterial contamination in platelet components. The system will be used in Filton (Bristol), Manchester and Colindale (London) where approximately 270,000 adult therapeutic doses of platelets are manufactured each year. NHSBT are seeking to engage with suppliers who can provide this. The system must be CE/UKCA marked. Additional requirements to be included with the managed service contract include:<br/>- continuous calibrated temperature monitoring<br/>- ability to integrate with NHSBT information management system<br/>- alerting software (for positive results, hardware errors, temperature excursions)<br/>- consumables (including, but not limited to, sterile sampling connecting devices)<br/><br/>All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and the Good Practice Guidelines for Blood Establishments that are Required to Comply with Directive 2005/62/EC. These are published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components. <br/><br/><br/>It is NHSBTs’ intention to engage with the market to gather detailed information about the market capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier Engagement days are likely to be a Webinar followed by individual supplier presentation days. Expressions of interest should be e-mailed to jo.murphy@nhsbt.nhs.uk by no later than 12:00 hours on 25th August 2022."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33696200",
            "scheme": "CPV",
            "description": "Blood-testing reagents"
          },
          {
            "id": "38434520",
            "scheme": "CPV",
            "description": "Blood analysers"
          },
          {
            "id": "48921000",
            "scheme": "CPV",
            "description": "Automation system"
          },
          {
            "id": "71632000",
            "scheme": "CPV",
            "description": "Technical testing services"
          },
          {
            "id": "85111810",
            "scheme": "CPV",
            "description": "Blood analysis services"
          },
          {
            "id": "71600000",
            "scheme": "CPV",
            "description": "Technical testing, analysis and consultancy services"
          },
          {
            "id": "85146000",
            "scheme": "CPV",
            "description": "Services provided by blood banks"
          },
          {
            "id": "71900000",
            "scheme": "CPV",
            "description": "Laboratory services"
          },
          {
            "id": "33698100",
            "scheme": "CPV",
            "description": "Microbiological cultures"
          }
        ]
      }
    ],
    "title": "Managed Service for the Bacterial Screening of Platelets",
    "value": {
      "amount": 31200000,
      "currency": "GBP"
    },
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This Prior Information Notice (PIN) follows 2021/S 000-013561 released on the 16th June 2021 and all information herein supersedes that of 2021/S 000-013561.<br/><br/>This Prior Information Notice (PIN) is separate to any tender opportunity and not related in any form whatsoever to any subsequent activity that NHSBT may wish to pursue. The purpose of this PIN is to consult the market to improve NHSBT’s knowledge on the status of manufacturer(s) or economic operator(s) that can supply a commercially available automated, high-throughput automated bacterial screening system which can detect bacterial contamination in platelet components. <br/>NHSBT needs to gauge market interest in a new provision of this service. It is the intention of NHSBT to further consult and engage with only those manufacturer(s) and economic operator(s) who meet the outline requirements.",
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome",
      "futureNoticeDate": "2022-11-01T00:00:00Z"
    },
    "classification": {
      "id": "85111810",
      "scheme": "CPV",
      "description": "Blood analysis services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-17015",
      "name": "NHS Blood and Transplant",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKK11",
        "locality": "Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "500 North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "buyerProfile": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "id": "NHS Blood and Transplant",
        "legalName": "NHS Blood and Transplant"
      },
      "contactPoint": {
        "name": "Jo Murphy",
        "email": "jo.murphy@nhsbt.nhs.uk",
        "telephone": "+44 1179212718"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}